Novartis Technical Analysis

<div class='circular--portrait' style='background:#347AFC;color: #ffffff;font-size:4em;padding-top: 25px;;'>NO</div>
NVS -- USA Stock  

Fiscal Quarter End: 30th of June 2020  

As of the 29th of May Novartis secures Downside Deviation of 3.14, Risk Adjusted Performance of 0.0173 and Mean Deviation of 2.13. In connection with Fundamental Indicators, Macroaxis technical analysis interface lets you check existing technical drivers of Novartis AG as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices or the prices will eventually revert. We found nineteen technical drivers for Novartis, which can be compared to its peers in the industry. Please verify Novartis AG Jensen Alpha and Semi Variance to decide if Novartis AG is priced some-what accurately providing market reflects its recent price of 86.97 per share. Given that Novartis AG has Jensen Alpha of (0.040168), we recommend you check Novartis last-minute market performance to make sure the company can sustain itself at future point.

Search Technical Analysis

Target PriceAdvice# of Analysts
Novartis AG current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Novartis Analyst Advice  

Novartis AG Technical Analysis

Time Period
  Portfolio Suggestion    
Execute Indicator
The output start index for this execution was five with a total number of output elements of fifty-six. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Novartis AG volatility. High ATR values indicate high volatility, and low values indicate low volatility. View also all equity analysis or get more info about average true range volatility indicators indicator.

Novartis AG Trend Analysis

Use this graph to draw trend lines for Novartis AG. You can use it to identify possible trend reversals for Novartis as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Novartis price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Novartis Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Novartis AG applied against its price change over selected period. The best fit line has a slop of   0.13  which may imply that Novartis AG will maintain its good market sentiment and make money for investors. It has 122 observation points and a regression sum of squares at 657.03, which is the sum of squared deviations for the predicted Novartis price change compared to its average price change.

About Novartis Technical Analysis

The Macroaxis Technical Analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Novartis AG on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Novartis AG based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Novartis AG stock first instead of the macroeconomic environment surrounding Novartis AG. By analyzing Novartis's financials, daily price indicators, and its related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Novartis's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Novartis specific price patterns or momentum indicators. Please read more on our technical analysis page.

Novartis May 29, 2020 Technical Indicators

Novartis May 29, 2020 Daily Price Condition

Additionally, see Stocks Correlation. Please also try Premium Stories module to follow macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page